These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. The prognostic value of high sensitivity cardiac troponin T in patients with congenital heart disease. Abiko M; Inai K; Shimada E; Asagai S; Nakanishi T J Cardiol; 2018 Apr; 71(4):389-393. PubMed ID: 29108668 [TBL] [Abstract][Full Text] [Related]
23. Congenital heart disease beyond the age of 60: emergence of a new population with high resource utilization, high morbidity, and high mortality. Tutarel O; Kempny A; Alonso-Gonzalez R; Jabbour R; Li W; Uebing A; Dimopoulos K; Swan L; Gatzoulis MA; Diller GP Eur Heart J; 2014 Mar; 35(11):725-32. PubMed ID: 23882067 [TBL] [Abstract][Full Text] [Related]
24. Predictive Value of V̇O Soares A; Park LK; Mansour E; Deych E; Puritz A; Zhao M; Cao C; Coggan AR; Barger PM; Foraker R; Racette SB; Peterson LR medRxiv; 2024 Oct; ():. PubMed ID: 39417096 [TBL] [Abstract][Full Text] [Related]
25. Predicting Outcomes Using the Heart Failure Survival Score in Adults with Moderate or Complex Congenital Heart Disease. Lin EY; Cohen HW; Bhatt AB; Stefanescu A; Dudzinski D; DeFaria Yeh D; Johnson J; Lui GK Congenit Heart Dis; 2015; 10(5):387-95. PubMed ID: 25358483 [TBL] [Abstract][Full Text] [Related]
26. High-sensitivity C-reactive protein in acute heart failure: insights from the ASCEND-HF trial. Kalogeropoulos AP; Tang WH; Hsu A; Felker GM; Hernandez AF; Troughton RW; Voors AA; Anker SD; Metra M; McMurray JJ; Massie BM; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Butler J J Card Fail; 2014 May; 20(5):319-26. PubMed ID: 24530944 [TBL] [Abstract][Full Text] [Related]
27. C-reactive protein decrease associates with mortality reduction only in heart failure with preserved ejection fraction. Lourenço P; Pereira J; Ribeiro A; Ferreira-Coimbra J; Barroso I; Guimarães JT; Leite-Moreira A; Bettencourt P J Cardiovasc Med (Hagerstown); 2019 Jan; 20(1):23-29. PubMed ID: 30407267 [TBL] [Abstract][Full Text] [Related]
28. Osteoprotegerin improves risk detection by traditional cardiovascular risk factors and hsCRP. Mogelvang R; Haahr-Pedersen S; Bjerre M; Frystyk J; Iversen A; Galatius S; Flyvbjerg A; Jensen JS Heart; 2013 Jan; 99(2):106-10. PubMed ID: 23135978 [TBL] [Abstract][Full Text] [Related]
29. Wait-List Outcomes for Adults With Congenital Heart Disease Listed for Heart Transplantation in the U.S. Alshawabkeh LI; Hu N; Carter KD; Opotowsky AR; Light-McGroary K; Cavanaugh JE; Bartlett HL J Am Coll Cardiol; 2016 Aug; 68(9):908-17. PubMed ID: 27561764 [TBL] [Abstract][Full Text] [Related]
30. GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study. Muhlestein JB; May HT; Galenko O; Knowlton KU; Otvos JD; Connelly MA; Lappe DL; Anderson JL Am Heart J; 2018 Aug; 202():27-32. PubMed ID: 29803983 [TBL] [Abstract][Full Text] [Related]
31. Inflammatory and Cholesterol Risk in the FOURIER Trial. Bohula EA; Giugliano RP; Leiter LA; Verma S; Park JG; Sever PS; Lira Pineda A; Honarpour N; Wang H; Murphy SA; Keech A; Pedersen TR; Sabatine MS Circulation; 2018 Jul; 138(2):131-140. PubMed ID: 29530884 [TBL] [Abstract][Full Text] [Related]
32. Clinical implications of eicosapentaenoic acid/arachidonic acid ratio (EPA/AA) in adult patients with congenital heart disease. Kanoh M; Inai K; Shinohara T; Tomimatsu H; Nakanishi T Heart Vessels; 2017 Dec; 32(12):1513-1522. PubMed ID: 28681101 [TBL] [Abstract][Full Text] [Related]
33. Health-Related Quality of Life and Its Association With Outcomes in Adults With Congenital Heart Disease and Heart Failure: Insight From FRESH-ACHD Registry. Ly R; Karsenty C; Amedro P; Cohen S; Domanski O; Godart F; Radojevic J; Vaksmann G; Naccache N; Boubrit A; Bataille V; Hascoet S; Ladouceur M J Am Heart Assoc; 2023 Apr; 12(8):e027819. PubMed ID: 37026543 [TBL] [Abstract][Full Text] [Related]
34. Integrating plasma high-sensitivity C-reactive protein and myeloperoxidase for risk prediction in chronic systolic heart failure. Tang WH; Shrestha K; Troughton RW; Borowski AG; Klein AL Congest Heart Fail; 2011; 17(3):105-9. PubMed ID: 21609382 [TBL] [Abstract][Full Text] [Related]
35. High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study. Elkind MS; Luna JM; Moon YP; Liu KM; Spitalnik SL; Paik MC; Sacco RL Neurology; 2009 Oct; 73(16):1300-7. PubMed ID: 19841382 [TBL] [Abstract][Full Text] [Related]
36. Can C-reactive protein predict cardiovascular events in asymptomatic patients? Analysis based on plaque characterization. Park HE; Cho GY; Chun EJ; Choi SI; Lee SP; Kim HK; Youn TJ; Kim YJ; Choi DJ; Sohn DW; Oh BH; Park YB Atherosclerosis; 2012 Sep; 224(1):201-7. PubMed ID: 22840693 [TBL] [Abstract][Full Text] [Related]
37. Adhesion molecules and C-reactive protein are associated to adverse events in angina pectoris. Eschen O; Christensen JH; Johnsen SP; Dethlefsen C; Schmidt EB Scand Cardiovasc J; 2010 Jun; 44(3):153-60. PubMed ID: 20184510 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure. Jug B; Salobir BG; Vene N; Sebestjen M; Sabovic M; Keber I Heart Vessels; 2009 Jul; 24(4):271-6. PubMed ID: 19626399 [TBL] [Abstract][Full Text] [Related]
39. Geriatric congenital heart disease: burden of disease and predictors of mortality. Afilalo J; Therrien J; Pilote L; Ionescu-Ittu R; Martucci G; Marelli AJ J Am Coll Cardiol; 2011 Sep; 58(14):1509-15. PubMed ID: 21939837 [TBL] [Abstract][Full Text] [Related]
40. Combined use of endothelial function assessed by brachial ultrasound and high-sensitive C-reactive protein in predicting cardiovascular events. Huang PH; Chen JW; Lu TM; Yu-An Ding P; Lin SJ Clin Cardiol; 2007 Mar; 30(3):135-40. PubMed ID: 17385705 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]